Clinical Trial Update: Assessment of Efficacy and Safety of Front-line Fludarabine, Cyclophoshamide and Ofatumumab Chemoimmunotherapy in Young Patients With Chronic Lymphocytic Leukemia. [Phase 2]

View source ↗

Summary

Phase 2 trial assessing frontline fludarabine, cyclophosphamide, and ofatumumab chemoimmunotherapy in young patients with B-cell lymphoid leukemia; study comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Fludarabine, Cyclophosphamide, and Ofatumumab chemoimmunotherapy

Snippet

Sponsor: Gruppo Italiano Malattie EMatologiche dell'Adulto | Conditions: B-cell Lymphoid Leukemia, Young Patients | Phase 2 | Status: COMPLETED